Internal Medicine, Pulmonary Disease · Hallandale Beach, FL
NPI
1508284118
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
701 N Federal Hwy # 601
Hallandale Beach, FL, 33009
Phone (954) 482-4747
Groups this clinician bills Medicare through
Medicare paid, 2024
$289K
3,016 services
Medicare patients, 2024
671
Average age 76
Drug cost, 2024
$591K
1,107 prescriptions
Company payments, 2025
$994
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armando Cabrera Alonso was code 99233 (hospital e&m - subsequent), 1,317 times for 218 patients. In total Armando Cabrera Alonso billed 3,016 services in 44 codes, and Medicare paid $289K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,317 | 218 | $103.21 | $136K |
| 99309 SNF E&M | Facility | 313 | 139 | $92.81 | $29K |
| 99223 Hospital E&M - Initial | Facility | 248 | 219 | $148.90 | $37K |
| 99214 Office E&M - Established | Office | 179 | 82 | $104.10 | $19K |
| 94664 E&M - Miscellaneous | Office | 122 | 60 | $15.65 | $1,909 |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 30 | $67.84 | $7,598 |
| 99291 Critical Care E&M | Facility | 91 | 44 | $189.74 | $17K |
| 99309 SNF E&M | Office | 67 | 45 | $94.41 | $6,326 |
| 94060 Pulmonary Function Testing | Office | 63 | 60 | $28.15 | $1,774 |
| 94729 Pulmonary Function Testing | Office | 63 | 60 | $42.54 | $2,680 |
| 94726 Pulmonary Function Testing | Office | 63 | 60 | $42.00 | $2,646 |
| 99305 SNF E&M | Facility | 52 | 51 | $113.56 | $5,905 |
| 99213 Office E&M - Established | Office | 48 | 34 | $70.17 | $3,368 |
| 94618 Pulmonary Function Testing | Office | 44 | 41 | $26.65 | $1,173 |
| 99204 Office E&M - New | Office | 26 | 26 | $140.82 | $3,661 |
By year: 2022 $194K for 2,378 services; 2023 $235K for 2,742 services; 2024 $289K for 3,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Armando Cabrera Alonso prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 183 prescriptions and refills. In total Armando Cabrera Alonso wrote 1,107 Medicare prescriptions that cost $591K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 183 | 219 | 49 | $137K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 140 | 182 | 56 | $3,691 |
| Prednisone Generic | 62 | 62 | 42 | $146 |
| Fluticasone Propionate Generic | 59 | 105 | 24 | $672 |
| Azelastine Hcl Generic | 51 | 86 | 26 | $1,022 |
| Azithromycin Generic | 46 | 50 | 31 | $339 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 43 | 47 | 20 | $28K |
| Symbicort Budesonide/Formoterol Fumarate | 36 | 43 | 11 | $7,825 |
| Montelukast Sodium Generic | 31 | 75 | 11 | $564 |
| Ipratropium Bromide Generic | 30 | 39 | 13 | $769 |
| Levofloxacin Generic | 27 | 27 | 24 | $140 |
| Breo Ellipta Fluticasone/Vilanterol | 27 | 30 | Under 11 | $11K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 23 | 23 | Under 11 | $2,428 |
| Ventolin Hfa Albuterol Sulfate | 22 | 23 | Under 11 | $1,198 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 19 | 19 | Under 11 | $8,822 |
Brand drugs: - claims; generic drugs: 572 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armando Cabrera Alonso $994 ($994 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $273.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $273 |
| Insmed, Inc. INSM | 12 | $161 |
| Genzyme Corporation SNY | 6 | $157 |
| GlaxoSmithKline, LLC. GSK | 4 | $101 |
| Grifols USA, LLC | 3 | $89.34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.7 |
| Vifor Pharma, Inc. | 2 | $49.08 |
| Lilly USA, LLC LLY | 2 | $39.38 |
| Inogen, Inc. INGN | 1 | $25.36 |
| Novo Nordisk Inc NVO | 1 | $24.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.